Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
|ClinicalTrials.gov Identifier: NCT00782691|
Recruitment Status : Unknown
Verified October 2008 by Radboud University.
Recruitment status was: Recruiting
First Posted : October 31, 2008
Last Update Posted : October 31, 2008
|Condition or disease||Intervention/treatment|
|Head and Neck Cancer||Other: CT-FDG/PET scan of the head-and-neck region|
|Study Type :||Observational|
|Estimated Enrollment :||15 participants|
|Official Title:||Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.|
|Study Start Date :||July 2008|
|Estimated Primary Completion Date :||December 2009|
Head-and-neck cancer patients.
Head-and-neck cancer patients eligible for therapeutic lymph node dissection of cervical nodes.
Other: CT-FDG/PET scan of the head-and-neck region
CT-FDG/PET scan of the head-and-neck region
- How accurate are the various FDG-PET segmentation tools? [ Time Frame: Measurements are performed in conjunction with the clinical pathologist directly postoperatively. ]
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00782691
|Contact: Dominic A.X. Schinagl, MD||NL24email@example.com|
|Radboud University Nijmegen Medical Centre||Recruiting|
|Nijmegen, Gelderland, Netherlands, 6500HB|
|Principal Investigator: Dominic AX Schinagl, MD|